Acid Citrate Dextrose (ACD) Tubes Market Share, Size, Key Players, Trends, Competitive And Regional Forecast

Acid Citrate Dextrose (ACD) Tubes Market: Introduction

  • Acid citrate dextrose, or ACD, is a solution of sodium citrate, citric acid, and dextrose in water, which is primarily used as an anticoagulant to preserve blood specimen. ACD tubes are specialized tubes utilized to preserve the whole blood specimen for future testing purpose. Several types of acid citrate dextrose tubes are available in the market. ACD tubes are primarily utilized in hospitals, clinics, and diagnostics centers worldwide.

Request Brochure –

  • Safety of the blood and blood components is an absolute necessity even though blood components provided by blood banks are free from bacteria, viruses, and other disease causing microorganisms. Risks that may arise during blood transfusion are a major cause of concern in the blood industry. Companies are considering blood decontamination as a step toward providing safe blood to patients. Hence, manufacturing companies are engaged in the development of advanced ACD tubes to preserve blood for longer time. Thus, advancement of ACD tubes is boosting the global demand for ACD tubes in hospitals, clinics, and diagnostics centers.

Key Drivers, Restraints, and Opportunities of Global Acid Citrate Dextrose (ACD) Tubes Market

  • Rising demand for storage of blood and blood components in blood banks, hospitals, and clinics to prevent contamination of blood components by microscopic organisms such as bacteria, viruses, and other disease-causing agents. Complications of contaminated blood transfusion could result in mild allergic reactions such as swelling of the hands, skin rash, feet, and legs along with high temperature. Hepatitis is a most common disease transmitted by blood transfusions. Rising cases of such infections is anticipated to fuel the acid citrate dextrose (ACD) tubes market during the forecast period.

Request COVID Analysis on Acid Citrate Dextrose (ACD) Tubes Market –

  • Most diagnostic assessments are performed on anti-coagulated plasma, serum, or whole blood. The findings of the diagnostic labs are based on blood specimens submitted and if the storage is not proper, it could lead to wrong diagnosis for the patient. As per the National Health Service (NHS), the number of people aged 65 years and above is expected to rise by 65% in the next 25 years. As per the World Health Organization (WHO), the global geriatric population is estimated to reach around 2 billion by 2050. Increase in the geriatric population is boosting the prevalence of cardiovascular diseases, arthritis, and cancer. Increase in these diseases propels the need for surgical interventions. In any surgical procedure performed on the patient, blood loss from the body and blood transfusion plays a vital role to maintain the required blood volume. Apart from the rise in surgical procedures, blood transfusion is also vital in accident cases and during dialysis conditions. New advancements in the development of ACD tubes are fueling diagnostic centers, health care centers, and clinics to adopt the use of advanced ACD tubes for long-term and short-term preservation of blood.

Request Customization on Acid Citrate Dextrose (ACD) Tubes Market Report –

North America to Capture Major Share of Global Acid Citrate Dextrose (ACD) Tubes Market

In terms of region, the global acid citrate dextrose (ACD) tubes market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America currently accounts for a prominent share of the global acid citrate dextrose (ACD) tubes market, primarily due to the robust demand for devices and increasing awareness among people about blood transfusion reaction. Europe accounted for the second-largest share of the global acid citrate dextrose (ACD) tubes market, after North America. A rise in the geriatric population and longer life expectancy has been majorly driving the acid citrate dextrose (ACD) tubes market in Europe. Asia Pacific comprises countries such as India, China, Australia, Japan, and Malaysia. Japan and China accounted for a notable share of the acid citrate dextrose (ACD) tubes market in Asia Pacific due to strong demand and increase in awareness about the device. Technological advancements is further expected to propel the market in the regions. The market in Latin America is primarily fuelled by investment in healthcare infrastructure in Brazil and Mexico.

Pre Book Acid Citrate Dextrose (ACD) Tubes Market Report –

Key Players Operating in Global Acid Citrate Dextrose (ACD) Tubes Market

The global acid citrate dextrose (ACD) tubes market is moderately competitive. Expansion of the market is estimated to prompt the entry of major players, increase competition, and subsequently, drive the market. Major players operating in the global acid citrate dextrose (ACD) tubes market are:

  • Fisher Scientific UK Ltd
  • Becton Dickinson and Company
  • Cryoquip LLC
  • Biomet, Inc.
  • Greiner Bio-One International GmbH
  • Merck KGaA
  • Cepham Life Sciences
  • BD

Trending Reports of Transparency Market Research –

Scar Treatment Market ––tmr-301292522.html

Lyophilized Injectable Market –

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]